about
Research progress on Livin protein: an inhibitor of apoptosisInhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activationAntisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.Effect of siRNA-Livin on drug resistance to chemotherapy in glioma U251 cells and CD133(+) stem cellsLocal injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrestExpression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma.Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer.Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo.siRNA targeting Livin decreases tumor in a xenograft model for colon cancerTherapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells.Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells.VEGF stimulation enhances Livin protein synthesis through mTOR signaling.siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells.LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.Silencing Livin improved the sensitivity of colon cancer cells to 5-fluorouracil by regulating crosstalk between apoptosis and autophagy.Livin is associated with the invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
P2860
Q24304472-FF61B757-A347-4D76-B5A3-AB624412B222Q33435646-5B65F6C6-D578-411C-BCBB-128C7A957D0EQ33892921-41E1DF6E-E411-4D82-95ED-41A895402150Q33933676-29860F76-B6DE-4B46-A097-B8B98A8EF47BQ34060255-12C10CBE-0354-4405-9641-8C0288FECA86Q34984334-1FA80345-BEC9-4092-A95C-6E16C3AE5695Q36081331-64D8A640-4B25-40FB-ADFD-2119117BD9F8Q36305414-4C1B22E1-4482-4141-9E1D-CD56EF27AAEEQ36611508-4AFD2C63-8FB0-4482-98D8-CAC1899F44E9Q36788045-E30018F1-F0E0-4EE7-BF8E-2E7FE87CBEFBQ37356468-7DDBD658-8281-4A66-B1B0-E62FE9C5EB2EQ37705961-4584D2BE-55FB-4E2A-9013-71A11DB100E6Q38400237-FF7DE58D-DD26-4AE9-835E-F95634A83516Q38705406-EFC3078A-46B7-4A09-9730-995CDBCDD74CQ39531905-1E970D82-AB62-409D-B9E4-4A4BCC5D3CCDQ39745633-13A7455F-E596-4B1B-8EFA-A3AAD83317C5Q40002468-88F31D9E-ADB1-4CD4-82EF-A0846A3F612AQ40046609-60D674F9-C21A-47F6-A1C8-1A19620697B6Q42934413-3975FF42-A980-46CC-8303-EE6130E6F788Q44804632-9C8C599F-5627-4903-BE99-D9D4AB81E838Q50674825-C18B4B06-A56F-4C21-A126-D01E86F9998EQ51351092-00B5B767-5A98-46AD-AAEA-3A1F37A38C26Q53685617-D8D4A6BA-F18D-40EE-B341-13C57B05C11BQ54344344-22E5FBAC-A43E-4803-910E-A76AB3675B52
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Livin/ML-IAP as a new target for cancer treatment.
@ast
Livin/ML-IAP as a new target for cancer treatment.
@en
type
label
Livin/ML-IAP as a new target for cancer treatment.
@ast
Livin/ML-IAP as a new target for cancer treatment.
@en
prefLabel
Livin/ML-IAP as a new target for cancer treatment.
@ast
Livin/ML-IAP as a new target for cancer treatment.
@en
P2093
P1433
P1476
Livin/ML-IAP as a new target for cancer treatment.
@en
P2093
P304
P356
10.1016/J.CANLET.2006.09.024
P407
P577
2007-01-10T00:00:00Z